Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis


Efe C., Al Taii H., Ytting H., Aehling N., Bhanji R. A. , Hagstrom H., ...More

DIGESTIVE DISEASES AND SCIENCES, vol.63, no.5, pp.1348-1354, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 63 Issue: 5
  • Publication Date: 2018
  • Doi Number: 10.1007/s10620-018-5011-x
  • Journal Name: DIGESTIVE DISEASES AND SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1348-1354
  • Hacettepe University Affiliated: Yes

Abstract

We studied the efficacy and safety of mycophenolate mofetil (MMF) and tacrolimus as second-line therapy in pediatric patients with autoimmune hepatitis (AIH) who were intolerant or non-responders to standard therapy (corticosteroid and azathioprine).